GENEVA, July 1 -- REMIX THERAPEUTICS INC. filed a patent application (US2025/059444) for “COMPOUNDS AND RELATED METHODS USEFUL FOR DEGRADATION OF CYCLIN K AND INHIBITION OF CYCLIN DEPENDENT KINASES”. With publication no. WO/2026/128832, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: C07D 401/14
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....